Autoimmune Hemolytic Anemia

From Citizendium
This article is a stub and thus not approved.
Main Article
Discussion
Definition [?]
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In hematology, Autoimmune hemolytic anemia (AIHA) is an "acquired hemolytic anemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red blood cells."[1]

Classification[edit]

Diagnosis[edit]

Treatment[edit]

As of 2010, no randomized controlled trials were available.[6] Subsequent studies are below.

Rituximab, a monoclonal antibody, was found to be safe by a systematic review of 21 studies, although only one was a randomized controlled trials.[7]

References[edit]



Download as ZWI file | Last modified: 12/27/2025 09:02:28 | 4 views
☰ Source: https://citizendium.org/wiki/Autoimmune_hemolytic_anemia | License: CC BY-SA 3.0

ZWI is not signed. [what is this?]